Dr. Sears is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1481 W 10th St
# 111P-IU
Indianapolis, IN 46202Phone+1 317-988-3918Fax+1 317-988-3976
Education & Training
- Indiana University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2011
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2005 - 2008
- Indiana University School of MedicineClass of 2005
Certifications & Licensure
- IN State Medical License 2008 - 2025
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy Start of enrollment: 2017 Apr 13
- Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules Start of enrollment: 2020 Dec 18
Publications & Presentations
PubMed
- 38 citationsDNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer.Catherine R. Sears, Sean A. Cooney, Helen Chin-Sinex, Marc S. Mendonca, John J. Turchi
DNA Repair. 2016-04-01 - 70 citationsEvaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy StatementPeter J. Mazzone, Catherine R. Sears, Doug A. Arenberg, Mina Gaga, Michael K. Gould
American Journal of Respiratory and Critical Care Medicine. 2017-09-29 - 83 citationsKnowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis An Official American Thoracic Society Research StatementCatherine R. Sears, Tobias Peikert, Jennifer D. Possick, Jarushka Naidoo, Mizuki Nishino
American Journal of Respiratory and Critical Care Medicine. 2019-09-15
Press Mentions
- bioAffinity Technologies Announces Dr. Martin Tammemägi to Chair Scientific and Medical Advisory BoardSeptember 29th, 2020
- Lung Cancer Screenings to Expand for Indiana Veterans Thanks to $1 Million GrantDecember 21st, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: